| Predicate |
Object |
| assignee |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentassignee/MD5_fef1346e16447e27f86dc6d5cbc609e6 |
| classificationCPCInventive |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61N5-1029 |
| classificationIPCInventive |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61M36-14
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61M36-00 |
| filingDate |
2000-08-15-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| grantDate |
2002-02-26-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| inventor |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_cd369fe76d193b74fdec2cd2b87631f1
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_e5b01fab86d74510d79581b08208fc3c |
| publicationDate |
2002-02-26-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| publicationNumber |
US-6350226-B1 |
| titleOfInvention |
Radioisotope bandage for reducing scar tissue formation |
| abstract |
Disclosed is a novel wound dressing which applies ionizing radiation to the surface of the wound as soon after the wound is created as is possible. Optimally, the radiation has a range which extends to the bottom surface of the skin but not significantly beyond that depth. An example of a radioactive source that can apply this type of radiation dosing is a beta particle emitting radioisotope such as phosphorous-32 which has a range of approximately 3.5 mm for 90% of the electrons that it emits. Even very small amounts of phosphorous-32 can provide a sufficiently high level of irradiation to significantly diminish scar tissue formation. The radioactive bandage would typically be an elongated flexible structure which can be applied along a wound or surgical incision. Typically, the radioactive bandage would extend for approximately 1 to 5 mm beyond the cut in all directions. The radioactive bandage would include a shield structure which surrounds the thin, elongated radioactive portion thus disallowing stray radiation outward from the patient's skin. A radiation dose applied to the top of the incision of between 500 and 2000 cGy can substantially reduce scar tissue formation for most patients. |
| isCitedBy |
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/US-9486642-B2
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/AU-2012266703-B2
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/US-2011201866-A1
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/US-2005074481-A1
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/US-7726318-B2
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/AU-2010200556-B2
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/AU-2010200556-A1
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/AU-2018219671-B2
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/US-8403996-B2
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/US-2011112655-A1
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/WO-2023076068-A3
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/US-10350433-B2
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/WO-2012168047-A1
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/US-7776100-B2
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/US-2003233136-A1
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/US-2007016179-A1
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/US-6575887-B1
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/US-7182726-B2
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/US-11351395-B2
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/US-7963997-B2 |
| priorityDate |
2000-08-15-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| type |
http://data.epo.org/linked-data/def/patent/Publication |